Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments

Xiaoquan Ding, Siheng Wang, Wenhe Jin, Xingwang Liu, Jun Chen, Shiyi ChenCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People’s Republic of ChinaPurpose: This study was designed to evaluate the in vitro and in vivo biocompati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ding X, Wang S, Jin W, Liu X, Chen J, Chen S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/0530bc83f0a548138b0a0cc9d9e2d5bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0530bc83f0a548138b0a0cc9d9e2d5bc
record_format dspace
spelling oai:doaj.org-article:0530bc83f0a548138b0a0cc9d9e2d5bc2021-12-02T01:05:05ZEncapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments1178-2013https://doaj.org/article/0530bc83f0a548138b0a0cc9d9e2d5bc2019-07-01T00:00:00Zhttps://www.dovepress.com/encapsulation-of-a-nanoporous-simvastatin-chitosan-composite-to-enhanc-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xiaoquan Ding, Siheng Wang, Wenhe Jin, Xingwang Liu, Jun Chen, Shiyi ChenCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People’s Republic of ChinaPurpose: This study was designed to evaluate the in vitro and in vivo biocompatibility and osteointegration of plasma-sprayed hydroxyapatite (HA)-coated polyethylene terephthalate (PET) ligaments encapsulated with a simvastatin (SV)-chitosan (CS) composite.Methods: This study compared the in vitro and in vivo bone responses to three different PET ligaments: SV/CS/PET-HA, CS/PET-HA and PET-HA. A field emission scanning electron microscope was used to characterize the morphology, and the in vitro SV release profile was analyzed. MC3T3 cells were cocultured with SV/CS/PET-HA, CS/PET-HA and PET-HA to test their biocompatibility using CCK-8 tests. Osteogenic differentiation was investigated by the expression of marker genes using qPCR. Osteointegration was performed by implanting the PET ligaments into the proximal tibia bone tunnels of male Sprague-Dawley rats for 3 weeks and 6 weeks. The bone-implant interface was evaluated by micro-computed tomography (micro-CT) and histological analysis.Results: The characteristic nanoporous structures mainly formed on the surface of the plasma-sprayed HA particles in the SV/CS/PET-HA and CS/PET-HA groups. The SV release test showed that the sustained release of simvastatin lasted for 25 days in the SV/CS/PET-HA group. The in vitro studies demonstrated that the SV/CS/PET-HA ligaments induced osteogenic differentiation in the MC3T3 cells, with higher mRNA expression levels of collagen-1, bone morphogenetic protein-2, osteocalcin and alkaline phosphatase than those in the CS/PET-HA and PET-HA ligament groups. The in vivo tests showed that both micro-CT analysis (bone mineral density and bone volume per total volume) and histological analysis (bone implant contact and interface area) revealed significantly higher peri-implant bone formation and less interface area in the SV/CS/PET-HA group than in the other groups.Conclusion: The SV-CS composite nanoporous structure was associated with the improved biocompatibility and osteogenic differentiation in vitro and enhanced osteointegration process in vivo of plasma-sprayed HA-coated PET ligaments.Keywords: simvastatin, chitosan, hydroxyapatite, osteointegration, polyethylene terephthalate  Ding XWang SJin WLiu XChen JChen SDove Medical PressarticleSimvastatinchitosanhydroxyapatiteosteointegrationpolyethylene terephthalateMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 4881-4893 (2019)
institution DOAJ
collection DOAJ
language EN
topic Simvastatin
chitosan
hydroxyapatite
osteointegration
polyethylene terephthalate
Medicine (General)
R5-920
spellingShingle Simvastatin
chitosan
hydroxyapatite
osteointegration
polyethylene terephthalate
Medicine (General)
R5-920
Ding X
Wang S
Jin W
Liu X
Chen J
Chen S
Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments
description Xiaoquan Ding, Siheng Wang, Wenhe Jin, Xingwang Liu, Jun Chen, Shiyi ChenCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People’s Republic of ChinaPurpose: This study was designed to evaluate the in vitro and in vivo biocompatibility and osteointegration of plasma-sprayed hydroxyapatite (HA)-coated polyethylene terephthalate (PET) ligaments encapsulated with a simvastatin (SV)-chitosan (CS) composite.Methods: This study compared the in vitro and in vivo bone responses to three different PET ligaments: SV/CS/PET-HA, CS/PET-HA and PET-HA. A field emission scanning electron microscope was used to characterize the morphology, and the in vitro SV release profile was analyzed. MC3T3 cells were cocultured with SV/CS/PET-HA, CS/PET-HA and PET-HA to test their biocompatibility using CCK-8 tests. Osteogenic differentiation was investigated by the expression of marker genes using qPCR. Osteointegration was performed by implanting the PET ligaments into the proximal tibia bone tunnels of male Sprague-Dawley rats for 3 weeks and 6 weeks. The bone-implant interface was evaluated by micro-computed tomography (micro-CT) and histological analysis.Results: The characteristic nanoporous structures mainly formed on the surface of the plasma-sprayed HA particles in the SV/CS/PET-HA and CS/PET-HA groups. The SV release test showed that the sustained release of simvastatin lasted for 25 days in the SV/CS/PET-HA group. The in vitro studies demonstrated that the SV/CS/PET-HA ligaments induced osteogenic differentiation in the MC3T3 cells, with higher mRNA expression levels of collagen-1, bone morphogenetic protein-2, osteocalcin and alkaline phosphatase than those in the CS/PET-HA and PET-HA ligament groups. The in vivo tests showed that both micro-CT analysis (bone mineral density and bone volume per total volume) and histological analysis (bone implant contact and interface area) revealed significantly higher peri-implant bone formation and less interface area in the SV/CS/PET-HA group than in the other groups.Conclusion: The SV-CS composite nanoporous structure was associated with the improved biocompatibility and osteogenic differentiation in vitro and enhanced osteointegration process in vivo of plasma-sprayed HA-coated PET ligaments.Keywords: simvastatin, chitosan, hydroxyapatite, osteointegration, polyethylene terephthalate  
format article
author Ding X
Wang S
Jin W
Liu X
Chen J
Chen S
author_facet Ding X
Wang S
Jin W
Liu X
Chen J
Chen S
author_sort Ding X
title Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments
title_short Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments
title_full Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments
title_fullStr Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments
title_full_unstemmed Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments
title_sort encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/0530bc83f0a548138b0a0cc9d9e2d5bc
work_keys_str_mv AT dingx encapsulationofananoporoussimvastatinchitosancompositetoenhanceosteointegrationofhydroxyapatitecoatedpolyethyleneterephthalateligaments
AT wangs encapsulationofananoporoussimvastatinchitosancompositetoenhanceosteointegrationofhydroxyapatitecoatedpolyethyleneterephthalateligaments
AT jinw encapsulationofananoporoussimvastatinchitosancompositetoenhanceosteointegrationofhydroxyapatitecoatedpolyethyleneterephthalateligaments
AT liux encapsulationofananoporoussimvastatinchitosancompositetoenhanceosteointegrationofhydroxyapatitecoatedpolyethyleneterephthalateligaments
AT chenj encapsulationofananoporoussimvastatinchitosancompositetoenhanceosteointegrationofhydroxyapatitecoatedpolyethyleneterephthalateligaments
AT chens encapsulationofananoporoussimvastatinchitosancompositetoenhanceosteointegrationofhydroxyapatitecoatedpolyethyleneterephthalateligaments
_version_ 1718403297128218624